Bovine viral diarrhea virus fetal persistent infection after immunization with a contaminated modified-live virus vaccine

Theriogenology

Volumn 79, Issue 8, 2013, Pages 1184-1195

  Palomares, Roberto A ^a   Marley, Shonda M ^b   Givens, M Daniel ^b   Gallardo, Rodrigo A ^c   Brock, Kenny V ^b  

^a UNIVERSITY OF GEORGIA   (United States)

^b AUBURN UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bovine viral diarrhea virus; BVDV 1; BVDV 2; Modified live virus vaccine; Persistent infection; Vaccine contamination

Indexed keywords

LIVE VACCINE;

ANIMAL; ANIMAL DISEASE; ARTICLE; BLOOD; BOVINE DIARRHEA VIRUS; BOVINE VIRAL DIARRHEA; CATTLE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE TRANSMISSION; DRUG CONTAMINATION; FEMALE; FETUS DISEASE; IMMUNOLOGY; ISOLATION AND PURIFICATION; OFF LABEL DRUG USE; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL DEVELOPMENT; RANDOMIZED CONTROLLED TRIAL; VACCINATION; VERTICAL TRANSMISSION; VIREMIA;

ANIMALS; BOVINE VIRUS DIARRHEA-MUCOSAL DISEASE; CATTLE; DIARRHEA VIRUS 1, BOVINE VIRAL; DRUG CONTAMINATION; FEMALE; FETAL DISEASES; INFECTIOUS DISEASE TRANSMISSION, VERTICAL; OFF-LABEL USE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VACCINATION; VACCINES, ATTENUATED; VIREMIA;

ANIMALIA; BOS; BOVINAE; BOVINE HERPESVIRUS 1; BOVINE RESPIRATORY SYNCYTIAL VIRUS; BOVINE VIRAL DIARRHEA VIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 2; HERPESVIRIDAE; HUMAN PARAINFLUENZA VIRUS 3; RESPIRATORY SYNCYTIAL VIRUS;

EID: 84876961142     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2013.02.017     Document Type: Article

References (64)

1. Lindenbach B.D., Rice C.M. Flaviviridae: the viruses and their replication. Fields virology 2001, 991-1041. Lippincott-Raven Publishers, Philadelphia. Fourth edition. D. Howley (Ed.).
2. Baker J. The clinical manifestation of bovine viral diarrhea infection. Vet Clin North Am Food Anim Pract 1995, 11:425-445.
3. Houe H. Epidemiological features and economical importance of bovine virus diarrhoea virus (BVDV) infections. Vet Microbiol 1999, 64:89-107.
4. Brock K.V., Grooms D.L., Givens M.D. Reproductive disease and persistent infections. Bovine viral diarrhea virus: diagnosis, management and control 2005, 145-156. Blackwell Publishing, Ames. S.M. Goyal, J. Ridpath (Eds.).
5. Peterhans E., Jungi T.W., Schweizer M. BVDV and innate immunity. Biologicals 2003, 31:107-112.
6. Potgieter L. Immunology of bovine viral diarrhea virus. Vet Clin N Am Food Anim Pract 1995, 11:501-520.
7. Donis R.O., Dubovi E.J. Molecular specificity of the antibody responses of cattle naturally and experimentally infected with cytopathic and noncytopathic bovine viral diarrhea virus biotypes. Am J Vet Res 1987, 48:1549-1554.
8. Hansen T.R., Smirnova N.P., Van Campen H., Shoemaker M.L., Ptitsyn A.A., Bielefeldt-Ohmann H. Maternal and fetal response to fetal persistent infection with bovine viral diarrhea virus. Am J Reprod Immunol 2010, 64:295-306.
9. McClurkin A.W., Littledike E.T., Cutlip R.C., Frank G.H., Coria M.F., Bolin S.R. Production of cattle immunotolerant to bovine viral diarrhea virus. Can J Comp Med 1984, 48:156-161.
10. Houe H., Baker J.C., Maes R.K., Wuryastuti H., Wasito R., Ruegg P.L. Prevalence of cattle persistently infected with bovine viral diarrhea virus in 20 dairy herds in two counties in central Michigan and comparison of prevalence of antibody positive cattle among herds with different infection and vaccination status. J Vet Diagn Invest 1995, 7:321-326.
11. Wittum T.E., Grotelueschen D.M., Brock K.V., Kvasnicka W.G., Floyd J.G., Kelling C.L. Persistent bovine viral diarrhoea virus infection in US beef herds. Prev Vet Med 2001, 49:83-94.
12. Loneragan G.H., Thomson D.U., Montgomery D.L., Mason G.L., Larson R.L. Prevalence, outcome, and health consequences associated with persistent infection with bovine viral diarrhea virus in feedlot cattle. J Am Vet Med Assoc 2005, 226:595-601.
13. Kelling C.L., Grotelueschen D.M., Smith D.R., Brodersen B.W. Testing and management strategies for effective beef and dairy herd BVDV biosecurity programs. Bovine Pr 2000, 34:13-21.
14. Brock K. Strategies for the control and prevention of bovine viral diarrhea virus. Vet Clin North Am Food Anim Pract 2004, 20:171-180.
15. Reber A.J., Tanner M., Okinaga T., Woolums A.R., Williams S., Ensley D.T., et al. Evaluation of multiple immune parameters after vaccination with modified live or killed bovine viral diarrhea virus vaccines. Comp Immunol Microbiol Infect Dis 2006, 29:61-77.
16. Brock K.V., Mc Carty K., Chase C.C.L., Harland R. Protection against fetal infection with either bovine viral diarrhea virus type 1 or type 2 using a noncytopathic type 1 modified-live virus vaccine. Vet Ther 2006, 7:27-34.
17. Dean H.J., Leyh R. Cross-protective efficacy of a bovine viral diarrhea virus (BVDV) type 1 vaccine against BVDV type 2 challenge. Vaccine 1999, 17:1117-1124.
18. Platt R., Widel P.W., Kesl L.D., Roth J.A. Comparison of humoral and cellular immune responses to a pentavalent modified live virus vaccine in three age groups of calves with maternal antibodies, before and after BVDV type 2 challenge. Vaccine 2009, 27:4508-4519.
19. Brock K.V., Cortese V.S. Experimental fetal challenge using type II bovine viral diarrhea virus in cattle vaccinated with modified-live virus vaccine. Vet Ther 2001, 2:354-360.
20. Cortese V.S., Grooms D.L., Ellis J., Bolin S.R., Ridpath J.F., Brock K.V. Protection of pregnant cattle and their fetuses against infection with bovine viral diarrhea virus type 1 by use of a modified-live virus vaccine. Am J Vet Res 1998, 59:1409-1413.
21. Dean H.J., Breck D., Hunsaker O., Bailey D., Wasmoen T. Prevention of persistent infection in calves by vaccination of dams with noncytopathic type-1 modified-live bovine viral diarrhea virus prior to breeding. Am J Vet Res 2003, 64:530-537.
22. Leyh R.D., Fulton R.W., Stegner J.E., Goodyear M.D., Witte S.B., Taylor L.P., et al. Fetal protection in heifers vaccinated with a modified-live virus vaccine containing bovine viral diarrhea virus subtypes 1a and 2a and exposed during gestation to cattle persistently infected with bovine viral diarrhea virus subtype 1b. Am J Vet Res 2011, 72:367-375.
23. Rodning S.P., Marley M.S., Zhang Y., Eason A.B., Nunley C.L., Walz P.H., et al. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus. Theriogenology 2010, 23:1154-1163.
24. Fulton R. Vaccines. Bovine viral diarrhea virus: diagnosis, management and control 2005, 209-222. Blackwell Publishing, Ames. S.M. Goyal, J. Ridpath (Eds.).
25. Bálint A., Baule C., Pálfi V., Belák S. Retrospective genome analysis of a live vaccine strain of bovine viral diarrhea virus. Vet Res 2005, 36:89-99.
26. Lancaster K.Z., Pfeiffer J.K. Mechanisms controlling virulence thresholds of mixed viral populations. J Virol 2011, 85:9778-9788.
27. Liess B., Orban S., Frey H.R., Trautwein G., Wiefel W., Blindow H. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus in cattle. II. Inoculation of pregnant cows without detectable neutralizing antibodies to BVD virus 90-229 days before parturition (51st to 190th day of gestation). Zentralbl Veterinarmed B 1984, 31:669-681.
28. Orban S., Liess B., Hafez S.M., Frey H.R., Blindow H., Sasse-Patzer B. Studies on transplacental transmissibility of a bovine virus diarrhoea (BVD) vaccine virus. I. Inoculation of pregnant cows 15 to 90 days before parturition (190th to 265th day of gestation). Zentralbl Veterinarmed B 1983, 30:619-634.
29. Roth J.A., Kaeberle M.L. Suppression of neutrophil and lymphocyte function induced by a vaccinal strain of bovine viral diarrhea virus with and without the administration of ACTH. Am J Vet Res 1983, 44:2366-2372.
30. Nuttall P.A., Luther P.D., Stott E.J. Viral contamination of bovine foetal serum and cell cultures. Nature 1977, 28:835-837.
31. Ridpath J. Practical significance of heterogeneity among BVDV strains: impact of biotype and genotype on U.S. control programs. Prev Vet Med 2005, 72:17-30.
32. Marley M.S., Givens M.D., Galik P.K., Riddell K.P., Stringfellow D.A. Development of a duplex quantitative polymerase chain reaction assay for detection of bovine herpesvirus 1 and bovine viral diarrhea virus in bovine follicular fluid. Theriogenology 2008, 70:153-160.
33. Studer E., Bertoni G., Candrian U. Detection and characterization of pestivirus contaminations in human live viral vaccines. Biologicals 2002, 30:289-296.
34. Deng R., Brock K. Molecular cloning and nucleotide sequence of a pestivirus genome, noncytopathic bovine viral diarrhea virus strain SD-1. Virology 1992, 191:867-879.
35. McKinley E.T., Hilt D.A., Jackwood M.W. Avian coronavirus infectious bronchitis attenuated live vaccines undergo selection of subpopulations and mutations following vaccination. Vaccine 2008, 26:1274-1284.
36. Van Santen V.L., Toro H. Rapid selection in chickens of subpopulations within ArkDPI-derived infectious bronchitis virus vaccines. Avian Pathol 2008, 37:293-306.
37. Xue W., Mattick D., Smith L., Umbaugh J.E.T. Vaccination with a modified live bovine viral diarrhea virus (BVDV) type 1a vaccine completely protected calves against challenge with BVDV type 1b strains. Vaccine 2010, 29:70-76.
38. Kelling C.L., Hunsaker B.D., Steffen D.J., Topliff C.L., Eskridge K.M. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves. Am J Vet Res 2007, 68:788-796.
39. Bolin S.R., Littledike E.T., Ridpath J.F. Serologic detection and practical consequences of antigenic diversity among bovine viral diarrhea viruses in a vaccinated herd. Am J Vet Res 1991, 52:1033-1037.
40. Kelling C.L., Stine L.C., Rump K.K., Parker R.E., Kennedy J.E., Stone R.T., et al. Investigation of bovine viral diarrhea virus infections in a range beef cattle herd. J Am Vet Med Assoc 1990, 197:589-593.
41. Van Campen H., Vorpahl P., Huzurbazar S., Edwards J., Cavender J. A case report: evidence for type 2 bovine viral diarrhea virus (BVDV)-associated disease in beef herds vaccinated with a modified-live type 1 BVDV vaccine. J Vet Diagn Invest 2000, 12:263-265.
42. Vilcek S., Björklund H.V., Horner G.W., Meers J., Belák S. Genetic typing of pestiviruses from New Zealand. N Z Vet J 1998, 46:35-37.
43. Jagodzinski L., Cooley J., Kelly T. Contamination of fetal bovine serum with bovine viral diarrhea virus: an issue for manufacturers of HIV-1 vaccines. 9th Conference on retroviruses and opportunistic infections 2002, 295-306. Foundation for Retrovirology and Human Health, Seattle. A.N.M. VanCott (Ed.).
44. Barkema H.W., Bartels C.J., van Wuijckhuise L., Hesselink J.W., Holzhauer M., Weber M.F., et al. Outbreak of bovine virus diarrhea on Dutch dairy farms induced by a bovine herpesvirus 1 marker vaccine contaminated with bovine virus diarrhea virus type 2. Tijdschr Diergeneeskd 2001, 15:158-165.
45. Falcone E., Tollis M., Conti G. Bovine viral diarrhea disease associated with a contaminated vaccine. Vaccine 1999, 18:387-388.
46. Falcone E., Cordioli P., Tarantino M., Muscillo M., Sala G., La Rosa G., et al. Experimental infection of calves with bovine viral diarrhoea virus type-2 (BVDV-2) isolated from a contaminated vaccine. Vet Res Commun 2003, 27:577-589.
47. Antonis A.F., van Oirschot J.T., van Es M., Bruschke C.J. ProducciónVaccination van kalveren met aangetaste partijen runder herpesvirus 1-vaccins heeft niet geleid tot een infectie met bovine virus diarree-virus. Tijdschr Diergeneeskd 2001, 126:208-211. [in Dutch].
48. Pastoret P.P. Human and animal vaccine contaminations. Biologicals 2010, 38:332-334.
49. Yanagi M., Bukh J., Emerson S.U., Purcell R.H. Contamination of commercially available fetal bovine sera with bovine viral diarrhea virus genomes: implications for the study of hepatitis C virus in cell cultures. J Infect Dis 1996, 174:1324-1327.
50. Rossi C.R., Bridgman C.R., Kiesel G.K. Viral contamination of bovine fetal lung cultures and bovine fetal serum. Am J Vet Res 1980, 41:1680-1681.
51. Bolin S.R., Matthews P.J., Ridpath J.F. Methods for detection and frequency of contamination of fetal calf serum with bovine viral diarrhea virus and antibodies against bovine viral diarrhea virus. J Vet Diagn Invest 1991, 3:199-203.
52. Audet S.A., Crim R.L., Beeler J. Evaluation of vaccines, interferons and cells. Substrates for pestivirus contamination. Biologicals 2000, 28:41-46.
53. Frey H.R., Eicken K., Grummer B., Kenklies S., Oguzoglu T.C., Moennig V. Foetal protection against bovine virus diarrhoea virus after two-step vaccination. J Vet Med 2002, 49:489-493.
54. Brock K.V., Chase C.C. Development of a fetal challenge method for the evaluation of bovine viral diarrhea virus vaccines. Vet Microbiol 2000, 77:209-214.
55. Zimmer G.M., Wentink G.H., Bruschke C., Westenbrink F.J., Brinkhof J., De Goey I. Failure of foetal protection after vaccination against an experimental infection with bovine virus diarrhea virus. Vet Microbiol 2002, 89:255-265.
56. Makoschey B., Janssen M.G.J. Investigation of a dual fetal infection model with bovine viral diarrhoea viruses (BVDV)-1 and BVDV-2. Arch Virol 2011, 156:1831-1833.
57. Bielefeldt-Ohmann H., Tolnay A.E., Reisenhauer C.E., Hansen T.R., Smirnova N., Van Campen H. Transplacental infection with non-cytopathic bovine viral diarrhoea virus types 1b and 2: viral spread and molecular neuropathology. J Comp Pathol 2008, 138:72-85.
58. Mittelholzer C., Moser C., Tratschin J.-D., Hofmann M.A. Porcine cells persistently infected with classical swine fever virus protected from pestivirus-induced cytopathic effect. J Gen Virol 1998, 79:2981-2987.
59. Lee Y., Tscherne D.M., Yun S., Frolov I., Rice C.M. Dual mechanisms of pestiviral superinfection exclusion at entry and RNA replication. J Virol 2005, 79:3231-3242.
60. Brock K.V., Brian D.A., Rouse B.T., Potgieter L.N. Molecular cloning of complementary DNA from a pneumopathic strain of bovine viral diarrhea virus and its diagnostic application. Can J Vet Res 1988, 52:451-457.
61. Hunsaker BD, Topliff C, Achenbach JA, Kelling CL. Back-passage of a commercial modified-live vaccine strain of type 1 noncytopathic bovine viral diarrhea virus did not result in reversion to virulence. In: Ellis RP, editor. Conference of Research Worker in Animal Diseases (CRWAD). Chicago. 2000. Abstract 187.
62. Jones L.R., Zandomeni R., Weber E.L. Quasispecies in the 5' untranslated genomic region of bovine viral diarrhoea virus from a single individual. J Gen Virol 2002, 83:2161-2168.
63. Gallardo R.A., van Santen V.L., Toro H. Host intraspatial selection of infectious bronchitis virus populations. Avian Dis 2010, 54:807-813.
64. Becher P., Orlich M., Konig M., Thiel H.J. Nonhomologous RNA recombination in bovine viral diarrhea virus: molecular characterization of a variety of subgenomic RNAs isolated during an outbreak of fatal mucosal disease. J Virol 1999, 73:5646-5653.